Suscribirse

Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study - 14/07/19

Doi : 10.1016/j.rehab.2019.06.002 
Alessio Baricich a, b, , Alessandro Picelli c, Stefano Carda d, Nicola Smania c, Carlo Cisari a, b, Andrea Santamato e, Alessandro de Sire a, f, Marco Invernizzi a
a Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy 
b Physical Medicine and Rehabilitation, University Hospital “Maggiore della Carità”, Novara, Italy 
c Neuromotor and Cognitive Rehabilitation Research Center, Department of Neurological, Biomedical and Movement Sciences, Università di Verona, Verona, Italy 
d Neuropsychology and Neurorehabilitation Service, Department of Clinical Neuroscience, Lausanne University Hospital (CHUV), Lausanne, Switzerland 
e Department of Physical Medicine and Rehabilitation, “OORR Hospital”, Università di Foggia, Foggia, Italy 
f Rehabilitation Unit, “Mons. L. Novarese” Hospital, Moncrivello, Vercelli, Italy 

Corresponding author. Physical Medicine and Rehabilitation, Department of Health Sciences, Università del Piemonte Orientale, Viale Piazza d’armi 1, 28100 Novara, Italy.Physical Medicine and Rehabilitation, Department of Health Sciences, Università del Piemonte OrientaleViale Piazza d’armi 1Novara28100Italy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity.
A wide range of adjunct therapies has been proposed to improve the BoNT-A effect, but the role of electrical stimulation (ES) of antagonist muscles is still unclear.
Our results do not support the use of ES of antagonist muscles after BoNT-A injection to plantar flexors muscles for post-stroke spasticity.
ES should probably be applied to injected muscles only, to boost the BoNT-A effect.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and should be offered as first-line treatment for focal manifestations. Although its possible role has been hypothesized, the efficacy of electrical stimulation (ES) of antagonists of the injected muscles for improving clinical outcome after BoNT-A injection remains to be established.

Objectives

This randomized single-blind pilot study aimed to investigate the efficacy of ES of antagonist muscles as adjunct treatment after BoNT-A injection to plantar flexor muscles in hemiplegic patients with spastic equinus foot.

Methods

After BoNT-A injection at triceps surae, patients were randomly allocated to 2 groups: group 1, single ES session on injected muscles plus 5 sessions of ES on antagonist muscles, and group 2, single ES session on injected muscles alone. Both groups underwent daily physical therapy for 60min for 2 weeks (5 days/week). Assessments were performed before treatment (T0) and at 10 days (T1), 20 days (T2), and 90 days (T3) after treatment. Our primary outcome was gait velocity at a comfortable speed at T2 (10-m walk test [10MWT]). The following were secondary outcomes: triceps surae spasticity (Modified Ashworth Scale), ankle passive range of motion (pROM), strength of tibialis anterior muscle, and 2-min walk test (2MWT).

Results

The 30 patients enrolled were randomly allocated to the 2 groups: 15 in group 1 and 15 in group 2. At T1, T2 and T3, both groups showed a significant reduction in muscle tone and an increase in ankle pROM (P<0.05). At T2 and T3, both groups showed a significant increase in 10MWT and 2MWT. The groups did not significantly differ in tibialis anterior strength or primary or secondary outcome measures.

Conclusions

ES of antagonist muscles does not improve clinical outcomes in the post-stroke spastic equinus foot after BoNT-A injection.

El texto completo de este artículo está disponible en PDF.

Keywords : Stroke, Spasticity, Botulinum toxin type A, Electrical stimulation, Rehabilitation


Esquema


© 2019  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 62 - N° 4

P. 214-219 - juillet 2019 Regresar al número
Artículo precedente Artículo precedente
  • Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin
  • Philippe Marque, Angelique Denis, David Gasq, Emmanuelle Chaleat-Valayer, Alain Yelnik, Cyrille Colin, Botuloscope Group 1, Dominic Pérennou
| Artículo siguiente Artículo siguiente
  • Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity?
  • Thierry Deltombe, Thierry Lejeune, Thierry Gustin

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.